Delivery Order SPE2DB22D2206-SPE2DB24FHF16
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx (relugolix) 120 mg tablets. It is a firm fixed-price delivery order contract with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Orgovyx (relugolix) 120 mg tablets. The contract has a ceiling value of $4,156.56 and a period of performance through May 14, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Orgovyx (relugolix) 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,626.24 and a period of performance through April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is for the supply of the prescription medication Orgovyx (relugolix) 120 mg tablets. The award has an ultimate completion date of May 29, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,385.52, is for the delivery of the medication Orgovyx (relugolix) 120 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,771.04, is for the delivery of the prescription medication Orgovyx (relugolix) 120 mg tablets. The contract is a firm fixed-price delivery order, with a performance period ending on May 27, 2025. This order is not designated as a set-aside contract, indicating open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $3,989.67 and is for the supply of the prescription drug Orgovyx (relugolix) 120 mg tablets. The contract is a firm fixed-price delivery order with a completion date of July 30, 2024. Amerisourcebergen, through its Corporate Office Division, is an experienced federal contractor that holds several...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,385.52, is a delivery order for the medication Orgovyx (relugolix) 120 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug Orgovyx (relugolix) 120 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,649.45 and a performance period through August 2024. The award does not utilize a socioeconomic set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Orgovyx 120 mg tablets. The contract has a firm fixed price of $1,385.52 and a period of performance through May 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHF16Delivery Order
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of the prescription medication Orgovyx (relugolix) 120 mg tablets, with a total ceiling value of $5,319.56 and a completion date of June 6, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a large pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain and logistics capabilities to efficiently fulfill government medical product requirements for the Department of Defense and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 5/15/24 |